← Open Payments lookup

ASHLEY EDGAR: Open Payments

NPI 1952009573 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$929 in 45 payments from 17 companies in 2025. Trend: 2023 $98 · 2024 $1,478 · 2025 $929

Food & beverage: $929
CompanyPaymentsAmount
UCB, Inc.9$205
Amgen Inc.13$166
PFIZER INC.3$118
GENZYME CORPORATION3$88
Axsome Therapeutics, Inc.2$50
Novartis Pharmaceuticals Corporation2$45
SpringWorks Therapeutics, Inc.2$44
ACADIA Pharmaceuticals Inc2$39
Boston Scientific Corporation1$26
AstraZeneca Pharmaceuticals LP1$24

Products named: REPATHA, Briviact, ZAVZPRET, Fintepla, Symbravo, LEQVIO, GOMEKLI, FABRAZYME.

Industry payments across TX — which companies pay providers there.